Roche ventana reagents - cleveland VAMC
Active Awarded Last action
- Contract number
- 36C25026N0399
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,011,633
Award facts
- Contract value 19% obligated
-
- $1,011,632.62 Current, with exercised options
- $5,370,896.53 Potential, with all options
- Completion date 60% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
About this award
Roche Diagnostics Corporation received a $5.37 million firm fixed-price delivery order from Veterans Integrated Service Network (VISN) 10 for Roche Ventana reagents to support the Cleveland Veterans Affairs Medical Center. The delivery order, awarded on March 19, 2026, carries an ultimate completion date of March 14, 2027, and represents a child contract under the In Vitro Diagnostics, Reagents, Test (FSS-65-VII) General Services Administration Schedule. The contract was awarded without a set-aside designation, reflecting open competition. Performance will take place in Castleton, Indiana, where Roche Diagnostics maintains a significant operational footprint for diagnostic product manufacturing and distribution.
This delivery order supports the Department of Veterans Affairs' laboratory testing and diagnostic capabilities through the supply of Ventana histology staining reagents and associated consumables. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, is a primary supplier of advanced diagnostic solutions to federal healthcare agencies, including the Veterans Health Administration, Defense Health Agency, and other civilian federal entities. The company maintains multiple active contracts across VISN networks for molecular diagnostics, histology services, immunochemistry testing, and laboratory instrumentation, with this VISN 10 award complementing existing indefinite delivery vehicles and blanket purchase agreements valued at approximately $2.0 million for COBAS 6800 testing services through December 2030.
Quick answers
Who was awarded contract 36C25026N0399?
36C25026N0399 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 10 (Veterans Health Administration) on March 19, 2026.
How much is contract 36C25026N0399 worth?
The government has obligated $1,011,633 on 36C25026N0399. Its potential value, with all options, is $5,370,897.
Is contract 36C25026N0399 an order under another contract?
Yes. 36C25026N0399 is a delivery order under 36F79722D0128, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25026N0399 competed?
The extent of competition for 36C25026N0399 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award